EUVIMEDEUVIMED entdecken
Crossref

Biosensor‐based active ingredient recognition system for screening potential small molecular Severe acute respiratory syndrome coronavirus 2 entry blockers targeting the spike protein from Rugosa rose

Wei Yu iD, Sheng-Zhe Yi, Cheng-Yu Jiang, Jia-Wei Guan, Rui Xue, Xu-Xuan Zhang, Tao Zeng, Hui Tang, Wen Chen, Bo Han iD

Biomedical Chromatography · 2024

DOI: 10.1002/bmc.5987 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Wei Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy/Key Laboratory of Xinjiang Phytomedicine Resource and Utilization/School of Medical, Shihezi University, Shihezi, China. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, Surface Plasmon Resonance, Gallic Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Independently Funded to Support Scientific Research Projects of Shihezi University, Major Science and Technology Projects of Xinjiang Uygur Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The traditional formulation Hanchuan zupa granules (HCZPs) have been widely used for controlling coronavirus disease 2019 (COVID‐19). However, its active components remain unknown. Here, HCZP components targeting the spike receptor‐binding domain (S‐RBD) of SARS‐CoV‐2 were investigated using a surface plasmon resonance (SPR) biosensor‐based active ingredient recognition system (SPR‐AIRS). Recombinant S‐RBD proteins were immobilized on the SPR chip by amine coupling for the prescreening of nine HCZP medicinal herbs. Ultra‐performance liquid chromatography‐tandem mass spectrometry (UPLC‐MS/MS) identified gallic acid (GA) and methyl gallate (MG) from Rosa rugosa as S‐RBD ligands, with K D values of 2.69 and 0.95 μM, respectively, as shown by SPR. Molecular dynamics indicated that GA formed hydrogen bonds with G496, N501, and Y505 of S‐RBD, and MG with G496 and Y505, inhibiting S‐RBD binding to angiotensin‐converting enzyme 2 (ACE2). SPR‐based competition analysis verified that both compounds blocked S‐RBD and ACE2 binding, and SPR demonstrated that GA and MG bound to ACE2 ( K D = 5.10 and 4.05 μM, respectively), suggesting that they blocked the receptor and neutralized SARS‐CoV‐2. Infection with SARS‐CoV‐2 pseudovirus showed that GA and MG suppressed viral entry into 293T‐ACE2 cells. These S‐RBD inhibitors have potential for drug design, while the findings provide a reference on HCZP composition and its use for treating COVID‐19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusSARS-CoV-2Surface Plasmon ResonanceGallic AcidRosaHumansAntiviral AgentsDrugs, Chinese HerbalAngiotensin-Converting Enzyme 2Tandem Mass SpectrometryBiosensing TechniquesVirus InternalizationCOVID-19 Drug TreatmentChromatography, High Pressure LiquidProtein BindingMolecular Dynamics SimulationCOVID-19

Stichwörter der Autor:innen

Rugosa roseSPR‐UPLC–MS/MSS‐RBD inhibitorgallic acidmethyl gallate

Substanzen

Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Gallic AcidAntiviral AgentsDrugs, Chinese Herbalmethyl gallateAngiotensin-Converting Enzyme 2

Autor:innen und Institutionen

  • School of Pharmacy/Key Laboratory of Xinjiang Phytomedicine Resource and Utilization/School of Medical, Shihezi University, Shihezi, China.
  • State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, China.
  • Corps Center for Food and Drug Evaluation and Verification, Xinjiang Production and Construction Corps Market Supervision Administration, Urumqi, China.

ORCID-Profile: Wei Yu, Bo Han

Förderung

  • National Natural Science Foundation of China
  • Independently Funded to Support Scientific Research Projects of Shihezi University
  • Major Science and Technology Projects of Xinjiang Uygur Autonomous Region
  • Fundamental Research Funds for the Central Universities
  • Open Funds for the State Key Laboratory of Natural and Biomimetic Drugs
  • Youth Innovation Training Talent Plan of Shihezi University
  • Shihezi University

Zitieren

APA

Yu, W., Yi, S. Z., Jiang, C. Y., Guan, J. W., Xue, R., Zhang, X. X., Zeng, T., Tang, H., Chen, W., & Han, B. (2024). Biosensor‐based active ingredient recognition system for screening potential small molecular Severe acute respiratory syndrome coronavirus 2 entry blockers targeting the spike protein from Rugosa rose. Biomedical Chromatography. https://doi.org/10.1002/bmc.5987

Vancouver

Yu W, Yi SZ, Jiang CY, Guan JW, Xue R, Zhang XX, et al. Biosensor‐based active ingredient recognition system for screening potential small molecular Severe acute respiratory syndrome coronavirus 2 entry blockers targeting the spike protein from Rugosa rose. Biomedical Chromatography. 2024. doi:10.1002/bmc.5987

BibTeX
@article{Yu2024,
  author = {Yu, Wei and Yi, Sheng-Zhe and Jiang, Cheng-Yu and Guan, Jia-Wei and Xue, Rui and Zhang, Xu-Xuan and Zeng, Tao and Tang, Hui and Chen, Wen and Han, Bo},
  title = {Biosensor‐based active ingredient recognition system for screening potential small molecular Severe acute respiratory syndrome coronavirus 2 entry blockers targeting the spike protein from Rugosa rose},
  journal = {Biomedical Chromatography},
  year = {2024},
  doi = {10.1002/bmc.5987}
}
Kostenlos starten →